Last edition
News about Biotechnology
Made Scientific and Pluristyx Partner to Advance iPSC Cell Therapies
Made Scientific and Pluristyx have launched a strategic partnership to streamline iPSC-derived cell therapy development and manufacturing. By integrating Pluristyx’s clinical-grade iPSC platform with Made Scientific’s CDMO services, the collaboration provides developers with a single-source pathway from cell line development to commercial supply.
Biotechnology | 08/06/2026 | By News Bureau | 218
Next-generation Nanomedicine can Silence Key Cancer Drivers: Research
Scientists in Pune have developed a next-generation precision nanomedicine that uses gene-silencing technology to target key cancer drivers and effectively inhibit breast tumor growth, highlighting a promising new approach for targeted breast cancer treatment and precision oncology.
Biotechnology | 04/06/2026 | By News Bureau | 176
Illumina Unveils Whole-Genome Sequencing Solution for Sensitive MRD Detection
Illumina has launched the first distributed Whole-Genome Sequencing (WGS) solution for highly sensitive Molecular Residual Disease (MRD) research, enabling faster and more flexible detection of the disease during and after treatment while expanding its next-generation oncology sequencing portfolio.
Biotechnology | 02/06/2026 | By News Bureau | 238
Leica Biosystems, AstraZeneca and Daiichi Sankyo have expanded their strategic collaboration to develop an AI-enabled immunohistochemistry assay and computational pathology solution for evaluating the TROP2 Normalised Membrane Ratio biomarker in NSCLC, aiming to advance biomarker-driven cancer research and future precision medicine approaches.<br />
Biotechnology | 01/06/2026 | By News Bureau | 205
Parse Biosciences and bit.bio have announced a strategic alliance to develop a comprehensive transcription factor-driven cell identity map, leveraging advanced single-cell sequencing and cell programming technologies to improve predictive drug discovery and scalable therapeutic research.
Biotechnology | 29/05/2026 | By News Bureau | 169
Biocytogen Launches AI-Powered RenSuper Platform to Accelerate Therapeutic Antibody Discovery
Biocytogen unveils RenSuper, a next-generation AI-driven antibody discovery and automation platform designed to streamline therapeutic biologics development and accelerate the delivery of innovative medicines worldwide.
Biotechnology | 28/05/2026 | By News Bureau | 234
Genethon and Ampersand Biomedicines Partner to Develop Precision Gene Therapy Vectors
Genethon and Ampersand Biomedicines join forces to engineer advanced AAV gene therapy vectors designed for greater tissue specificity, potentially enabling safer and more effective treatments for patients with rare genetic disorders.
Biotechnology | 25/05/2026 | By News Bureau | 170
Incyte and Genesis Molecular AI have expanded their strategic collaboration to deploy advanced molecular AI technologies and proprietary research data, aiming to accelerate drug discovery and develop next-generation therapies through AI-powered molecular design.
Biotechnology | 22/05/2026 | By News Bureau | 367
Dr. Jitendra Singh Launches UMMID Program, Highlights Future of Genomic and Precision Medicine
Dr. Jitendra Singh dedicates the UMMID Program to the nation, highlighting the growing role of genomic and precision medicine in advancing early intervention, personalised treatment, and affordable healthcare for rare genetic disorders in India.
Biotechnology | 22/05/2026 | By News Bureau | 238
TDB-DST Backs Helix Cell Therapeutics for CAR-T Therapy against Multiple Myeloma
Technology Development Board (TDB) supports Helix Cell Therapeutics and Biocell Innovations in developing dual-targeting CAR-T cell therapy for multiple myeloma under an Indo-Singapore collaboration.
Biotechnology | 14/05/2026 | By News Bureau | 178
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy